Substance Abuse and Mental Health Services Administration October 2023 – Federal Register Recent Federal Regulation Documents

Reorganization of the Center for Mental Health Services
Document Number: 2023-23805
Type: Notice
Date: 2023-10-30
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Statement of Organization, Functions, and Delegations of Authority. The Substance Abuse and Mental Health Services Administration has modified its structure. This new organizational structure was approved by the Secretary of Health and Human Services on October 11, 2023, and became effective on October 26, 2023.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2023-23319
Type: Notice
Date: 2023-10-23
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2023-23240
Type: Notice
Date: 2023-10-20
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2023-22972
Type: Notice
Date: 2023-10-18
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Meeting
Document Number: 2023-22797
Type: Notice
Date: 2023-10-17
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Request for Information; Potential Changes to its Evidence-Based Practices Resource Center; Notice of Correction
Document Number: 2023-22792
Type: Notice
Date: 2023-10-16
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration published a document in the Federal Register of September 7, 2023, announcing a Notice of request for information (RFI). The document contained incorrect date in the DATES section.
Notice of Meeting for the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC)
Document Number: 2023-22157
Type: Notice
Date: 2023-10-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Secretary of Health and Human Services (Secretary) announces a meeting of the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC). The ISUDCC is open to the public and members of the public can attend the meeting via telephone or webcast only, and not in person. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at: https://www.samhsa.gov/ about-us/advisory-councils/meetings. The meeting will include reports from the ISUDCC Working Groups, and discussion of the ISUDCC's recommendations to HHS on how the Federal Government can further integrate and coordinate harm reduction approaches and strategies across the continuum of prevention, treatment, and recovery policies, programs, and practices.
Tribal Opioid Response (TOR) Consultation
Document Number: 2023-21967
Type: Notice
Date: 2023-10-04
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
SAMHSA announces a Tribal Consultation Session on the Tribal Opioid Response (TOR) grant funding methodology. SAMHSA will host American Indian and Alaska Native (AI/AN) Federally Recognized Tribes for a virtual Tribal consultation session.
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
Document Number: 2023-21689
Type: Notice
Date: 2023-10-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine or Oral Fluid (Mandatory Guidelines).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.